肝纤维化逆转的病理评估

王冰琼; 孙亚朦; 尤红; 邵晨; 王泰龄

doi:10.3969/j.issn.1001-5256.2017.03.007

肝纤维化逆转的病理评估

DOI: 10.3969/j.issn.1001-5256.2017.03.007

1. 首都医科大学附属北京友谊医院肝病中心，国家消化系统疾病临床医学研究中心
2. 首都医科大学附属北京佑安医院病理科
3. 中日友好医院病理科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 2915
- HTML全文浏览量: 68
- PDF下载量: 572
- 被引次数: 0
出版历程
- 出版日期: 2017-03-20

Pathological assessment of liver fibrosis regression

Liver Research Center, Beijing Friendship Hospital

摘要

摘要: 肝纤维化是慢性肝脏疾病的共同病理结局,准确评估肝纤维化程度对明确疾病诊断、治疗决策、监测疗效及判断预后均有重要参考价值。目前已有多项临床研究证实,经过有效治疗肝纤维化/早期肝硬化是可以逆转的,如何正确评价肝纤维化逆转成为临床研究热点。肝活组织检查一直以来都是肝纤维化评价的金标准,因此其对纤维化逆转评价至关重要。从半定量、定量、定性评价3个方面回顾了现有肝纤维化病理分期标准在肝纤维化逆转中的临床应用进展,以提出更好的病理评价体系评估肝纤维化逆转。
- 肝硬化 /
- 逆转 /
- 病理过程
Abstract: Hepatic fibrosis is the common pathological outcome of chronic hepatic diseases.An accurate assessment of fibrosis degree provides an important reference for a definite diagnosis of diseases, treatment decision-making, treatment outcome monitoring, and prognostic evaluation.At present, many clinical studies have proven that regression of hepatic fibrosis and early-stage liver cirrhosis can be achieved by effective treatment, and a correct evaluation of fibrosis regression has become a hot topic in clinical research.Liver biopsy has long been regarded as the gold standard for the assessment of hepatic fibrosis, and thus it plays an important role in the evaluation of fibrosis regression.This article reviews the clinical application of current pathological staging systems in the evaluation of fibrosis regression from the perspectives of semi-quantitative scoring system, quantitative approach, and qualitative approach, in order to propose a better pathological evaluation system for the assessment of fibrosis regression.
- liver cirrhosis /
- reverse /
- pathologic processes

HTML全文

参考文献(24)

[1]LIAW YF.Reversal of cirrhosis:an achievable goal of hepatitis B antiviral therapy[J].J Hepatol, 2013, 59 (4) :880-881.

[2]MALEKZADEH R, MOHAMADNEJAD M, RAKHSHANI N, et al.Reversibility of cirrhosis in chronic hepatitis B[J].Clin Gastroenterol Hepatol, 2004, 2 (4) :344-347.

[3]KNODELL RG, ISHAK KG, BLACK WC, et al.Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis[J].Hepatology, 1981, 1 (5) :431-435.

[4]SCHEUER PJ.Classification of chronic viral hepatitis:a need for reassessment[J].J Hepatol, 1991, 13 (3) :372-374.

[5]ISHAK K, BAPTISTA A, BIANCHI L, et al.Histological grading and staging of chronic hepatitis[J].J Hepatol, 1995, 22 (6) :696-699.

[6]BEDOSSA P, POYNARD T.An algorithm for the grading of activity in chronic hepatitis C.The METAVIR Cooperative Study Group[J].Hepatology, 1996, 24 (2) :289-293.

[7]DIENSTAG JL, GOLDIN RD, HEATHCOTE EJ, et al.Histological outcome during long-term lamivudine therapy[J].Gastroenterology, 2003, 124 (1) :105-117.

[8]CHANG TT, LIAW YF, WU SS, et al.Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B[J].Hepatology, 2010, 52 (3) :886-893.

[9]MARCELLIN P, GANE E, BUTI M, et al.Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B:a 5-year open-label follow-up study[J].Lancet, 2013, 381 (9865) :468-475.

[10]D'AMBROSIO R, AGHEMO A, RUMI MG, et al.A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis[J].Hepatology, 2012, 56 (2) :532-543.

[11] CHEVALLIER M, GUERRET S, CHOSSEGROS P, et al.A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens:comparison with morphometric studies[J].Hepatology, 1994, 20 (2) :349-355.

[12]KIM SU, OH HJ, WANLESS R, et al.The Laennec staging systemfor histological sub-classification of cirrhosis is useful for stratification of prognosis in pattients with liver cirrhosis[J].J Hepatol, 2012, 57 (3) :556-563.

[13]BEDOSSA P.Reversibility of hepatitis B virus cirrhosis after therapy:who and why?[J].Liver Int, 2015, 35 (Suppl 1) :78-81.

[14]TENG XY, ZHOU XG, SUN L, et al.Application of a refined fibrosis staging system to evaluate therapeutic efficacy in chronic viral hepatitis[J].Chin J Hepatol, 2013, 21 (4) :271-274. (in Chinese) 滕晓英, 周新刚, 孙磊, 等.细化慢性肝炎肝纤维化分期标准在药物疗效评定中的应用[J].中华肝脏病杂志, 2013, 21 (4) :271-274.

[15]JIMENEZ W, PARS A, CABALLERA J, et al.Measurement of fibrosis in needle liver biopsies:evaluation of a colorimetric method[J].Hepatology, 1985, 5 (5) :815-818.

[16]MANOUSOU P, DHILLON AP, ISGRO G, et al.Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation[J].Liver Transpl, 2011, 17 (2) :178-188.

[17]TSOCHATZIS E, BRUNO S, ISGRO G, et al.Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis[J].J Hepatol, 2014, 60 (5) :948-954.

[18]ARIMA M, TERAO H, KASHIMA K, et al.Regression of liver fibrosis in cases of chronic liver disease type C:quantitative evaluation by using computed image analysis[J].Intern Med, 2004, 43 (10) :902-910.

[19]GOODMAN ZD, BECKER RL Jr, POCKROS PJ, et al.Progression of fibrosis in advanced chronic hepatitis C:evaluation by morphometric image analysis[J].Hepatology, 2007, 45 (4) :886-894.

[20]O'BRIEN MJ, KEATING NM, ELDERINY S, et al.An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C[J].Am J Clin Pathol, 2000, 114 (5) :712-718.

[21]WANG Y, HOU JL.Fibrosis assessment:impact on current management of chronic liver disease and application of quantitative invasive tools[J].Hepatol Int, 2016, 10 (3) :448-461.

[22]XU S, WANG Y, TAI DC, et al.qF ibrosis:a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients[J].JHepatol, 2014, 61 (2) :260-269.

[23]WANG Y, HOU JL.Current strategies for quantitating fibrosis in liver biopsy[J].Chin Med J (Engl) , 2015, 128 (2) :252-258.

[24]WANLESS IR, NAKASHIMA E, SHERMAN M.Regression of human cirrhosis.Morphologic features and the genesis of incomplete septal cirrhosis[J].Arch Pathol Lab Med, 2000, 124 (11) :1599-1607.

施引文献

资源附件(0)

访问统计